Introduction: Respiratory Distress Syndrome (RDS) is a common cause of mortality and morbidity in preterm. It is the commonest indication for ventilation in neonates in India. Surfactant Replacement Therapy (SRT) for RDS is a major breakthrough that has revolutionized the survival of premature infants worldwide. Randomized controlled trials have also demonstrated that prophylactic or early surfactant therapy compared with delayed surfactant treatment results in improved outcomes for preterm infants at high risk. Objective: To assess the outcome of early and late rescue surfactant administration by InSuRE (Intubation, Surfactant and Rapid Extubation) technic in managing preterm neonates with respiratory distress syndrome (RDS). Methodology: Study design: Prospective analytical study. Sample size: 144 preterm babies between 28-34 weeks of GA. Setting: Level III NICU at SVRR Government General Hospital, Tirupati, AP. Study Period: 1 year (Sep 2013 to Aug 2014). Method: All preterm babies between 28-34 weeks with respiratory distress were given surfactant with InSuRE technic immediately and categorized into early and late rescue group depending on the time of surfactant therapy i.e. within 2 hrs. of life and between 2-24 hrs. of life respectively. Results: In early rescue group there is significant reduction in mortality and lessen the need of mechanical ventilation with p value <0.05. Conclusion: Early routine surfactant administration within 2 hrs. of life as compared to late selective administration significantly reduced the need mechanical ventilation within 7th day of life and mortality among preterm with respiratory distress syndrome.
INTRODUCTION
Respiratory Distress Syndrome (RDS) is a common cause of mortality and morbidity in preterm. It is the commonest indication for ventilation in neonates in India. 1, 2, 3. Surfactant replacement therapy (SRT) for RDS is a major breakthrough that has revolutionized the survival of premature infants worldwide 1-4. The National Neonatal Forum of India, (NNF) in 1999 published a data on 145,623 consecutively born neonates at 15 centers 5 . These data show a prematurity rate of 14.5%. Among the 21,125 preterm infants, there were 1,674 with the diagnosis of RDS (8% of preterm infants) accounting for 1.2% of all births. There was no information regarding the use of surfactant. Based on these data from India with annual births of 27 million, the number of preterm births can be estimated to be over 4 million/year and the annual number of infants with RDS over 300,000. The very large number of preterm births and cases of RDS pose a great challenge to clinicians and the national health planners in India 1 . The main cause of the disease is inadequate production of lung surfactant. Surfactant replacement reduces mortality and morbidity rates in premature infants, reduces duration of ventilator support, number of complications and medical costs. Surfactant replacement therapy changes the natural history of RDS, resulting in up to 40% relative reduction in neonatal mortality and in 30-65% relative reduction in risk for pneumothorax 4 .
Randomized controlled trials have also demonstrated that prophylactic or early surfactant therapy compared with delayed Address for correspondence* Dr.A.S.KIREETI, Associate Professor, Department of Pediatrics, SVRR Government General Hospital, Tirupati 517501. A.P. India. Email: askireeti@gmail.com surfactant treatment results in improved outcomes for preterm infants at high risk [4] [5] [6] [7] [8] 9 .
Early administration of surfactant may prevent CPAP failure, need for ventilation [10] [11] [12] [13] [14] [15] [16] [17] [18] and also reduce the duration of CPAP. In our center, all infants with RDS who do not require intubation during resuscitation and develop respiratory distress are given Rescue surfactant kept on CPAP immediately. This study was planned to evaluate the efficacy of surfactant with respect to gestational age, birth weight basis and also early routine surfactant as compared to late selective administration in infants with RDS being managed on CPAP. We hypothesized that moderate-sized preterm infants (gestation 28 0/7 to 33 6/7 weeks) with RDS on CPAP would have lesser need for MV in the first 7 days of life, when treated with surfactant within the first 2 h of life, compared with those treated late.
MATERIAL AND METHODS
A prospective analytical study conducted in all preterm babies between 28-34 weeks of gestation admitted for respiratory distress in level III Neonatal referral unit in the Department of Pediatrics, SVRR Government General Hospital, Tirupati during the period from September 2013 to August 2014. Preterm babies with perinatal asphyxia, congenital anomalies, Pneumothorax, meconium aspiration syndrome and congenital pneumonia are excluded from the study. Institutional Ethical Committee (IEC) approval was obtained prior to starting of the study. Informed consent was taken from the parents before enrolling the babies in study.
All the Preterm neonates between 28 to 34 weeks of gestation (assessment by New Ballard Score) and birth weight between 1000 to 1800 grams admitted with signs of respiratory distress as per Silverman Anderson Score included in the study duly excluding the exclusion criteria. All the babies with respiratory distress were given surfactant immediately and categorized to early and late rescue depending up on the time of surfactant therapy i.e., with in 2 hrs. of life and between 2 to 24 hrs of life respectively. Surfactant was given by InSuRE technic i.e. Surfactant was instilled directly into the lungs through the endotracheal tube under strict aseptic conditions 17 . Once intubated a smaller size (5 Fr) nasogastric tube cut short to the length of ETT is introduced through the ETT. The desired dose is loaded into a sterile syringe given as a bolus over 15 min in 2-4 aliquots. Natural surfactant (bovine) was administered in a dose of 100mg/kg in 4 aliquots. Positive Pressure Ventilation was administered after each aliquot with self-inflating neonatal resuscitation bag with mask pressure limited to 30 cm of water. After completion of surfactant administration if oxygen saturations were maintained [87-93%] neonate was extubated back to CPAP [InSuRE] .
Adjustment in continuous distending pressure was based on chest retractions, and SPO2 with maximum pressures limit of 7cm of water. FiO2 was adjusted to maintain SPO2 between 87-93%. When the infant was stable on CPAP pressure of 4cm with FiO2 < 0.25 for 8-12 hours, CPAP was discontinued and infant was shifted to head box oxygen. Post procedure babies were monitored based on Silverman Anderson score with respect to need of oxygen / need of CPAP / mechanical ventilation. Secondary outcome was assessed in terms of following parameters: Need of mechanical ventilation within day 7 of life, duration on CPAP in hrs median, duration on mechanical ventilation in hours, pneumothorax, PDA, culture positive sepsis, IVH, oxygen dependence at 28 days of life, oxygen dependence at 36 weeks of life.
Neonatal data was collected using predesigned and pretested proforma. The results for each parameter were presented in tables and charts. Statistical Data analysis was carried out using MS excel, EPI -info 3.5.1 version. For determining significance of each test p value was used. The p value of less than 0.05 was accepted as indicating statistical significance.
RESULTS
Total 144 preterm babies with respiratory distress were given surfactant by InSuRE technic. Majority of preterm in present study group had a birth weight of 1500-1799gms (40%), those between 1250-1499gms are (36.7%) and those between 1000-1249 accounting for 23.30%. No. of preterm new born babies those who received surfactant within 2 hours of life i.e., early rescue were 49 babies (34%) and 95 babies (66%) received more than 2 hours after birth but within 24 hrs of life. At 36 weeks of life 1 case out of 49 cases (2.0) was on oxygen requirement compared to 6 cases out of 95 cases which is 6.3% in late rescue group.
SECONDARY OUTCOME INCIDENCE OF VARIOUS PARAMETERS IN EARLY AND LATE RESCUE

Figure 1: Incidence of Secondary Outcome In Early And Late Rescue
It can be seen from the above bar diagram that need for mechanical ventilation and thereby incidence of sepsis was significantly higher in late rescue therapy when compared to early rescue therapy. Incidence of complications like pneumothorax, PDA, IVH, CLD were also higher in late rescue therapy when compared to early rescue therapy.
DISCUSSION
Respiratory distress due to various causes afflicts 5-12% of neonates in our country. Hyaline membrane disease is a major cause of respiratory distress in preterm new born. The incidence of Hyaline membrane disease is reported to be 6.8% to 14.1% of preterm live births in our country. At gestational ages of 29-30 wks., the incidence is as high as 32% while at 28 weeks, the incidence is not well documented.
HMD is the commonest indication of ventilation in neonates in our country. The reported survival of babies ventilated for HMD has varied from 25% to 64% in our country. In the present study, incidence is high in all age groups when compared to Anil Narang et al., reason for high incidence could be due to less administration of antenatal steroid 24 hrs. prior to delivery which decreases incidence of RDS. Incidence Respiratory distress in babies with birth weight 1000-1249 grams was observed as 23.3% in present study compared to 24% in a study of Anil Narang et al which is almost same in both studies. Among 1250-1499 grams group it was 36.7% in present study and 28.4% in Anil Narang et al. 40 % of incidence was noted in babies of birth weight 1500-1749.
Incidence of RDS is higher in 1250 to 1800gms in present study which can be explained by decreased number of booked cases and decreased administration of antenatal steroids prior to delivery. Mortality was higher among 28-30 wks. gestational age group in the present study(50%) which is comparable to 50% in a study by Anil Narang et al. Between 30-32 weeks it is 39.1% which is slightly more when compared to Anil Narang et al.
Mortality among 32-34 wks. Gestational age group in present study was 35% which is higher compared to 26% in a study by Anil Narang et al.
Reason for higher mortality in present study could be explained by the observation that incidence of unbooked pregnancies and perinatal complications are high. And also the incidence of PROM is more in present study which is an additive factor for increased incidence of sepsis leading to higher mortality Mortality was higher(54.5%) among babies with birth weight 1000-1249 grams in present study compared to 44.1% in a study by Huanhuan et al. Between 1250-1499 grams there is 40 % mortality which is significantly higher when compared to Huanhuan et al.,
Mortality among 1500-1799 weight group was much higher (36.2%) when compared to a study by Huanhuan et al., which is only 13%. Survival rate among babies who were administered early rescue surfactant was 71.5 % in present study when compared to a much higher survival rate (87.8%) in a study by Hemasree et al. This may be due to other factors like PDA, IVH, and culture positive sepsis.
6.1% of babies born before 32 wks. Gestational age were oxygen dependent on 28th day of life in present study compared to 2.7% in a study by Hemasree et al.
2.0% babies born > 32 wks. Gestational age were oxygen dependent at 36 wks. of life in present study whereas none were oxygen dependent in a study by Hemasree et al. higher incidence of oxygen dependency may be due to increased requirement of mechanical ventilation which affects the outcome of present study.
In a study by Verder et al, 37% babies were oxygen dependent at 28 days of life which was much higher compared to present study.
52.6% cases who were given late rescue surfactant needed mechanical ventilation within 7 days of life compared to 27% of early rescue surfactant babies in present study.
Percentage of babies who were oxygen dependent at 28 days of life was higher after late rescue surfactant in present study when compared to study by Hemasree et al., and Verder et al., which could be explained by increased need of mechanical Secondary outcome was assessed in the form of factors affecting the success of surfactant (Early and late rescue) and duration of oxygen dependency and need for mechanical ventilation.
In present study, 13 cases out of 49 cases accounting for 26.5% cases needed mechanical ventilation within 7 days of life, which is higher compared to 16.2% in a study by Hemasree et al.
ventilation in the present study.
Incidence of PDA, culture positive sepsis, IVH, prolonged need of mechanical ventilation was higher among babies who were given late rescue surfactant in present study. 
CONCLUSIONS
Through InSuRE technic there was reduction in mortality among preterm with respiratory distress syndrome with increase in gestational age and birth weight. Early rescue surfactant administration within 2 hrs of life as compared to late selective administration significantly reduced the need of mechanical ventilation in the first week of life and mortality among preterm infants with respiratory distress syndrome.
